Aspen Neuroscience Launches First Patient Screening Study for Planned Clinical Trial of Personalized Cell Replacement in Parkinson's Disease

/PRNewswire/ -- Aspen Neuroscience, Inc., a private biotechnology company developing induced pluripotent stem cell (iPSC)-derived cell therapies, including the...

Related Keywords

United States ,San Diego ,California ,Americans ,Damien Mcdevitt ,Aspen Neuroscience Inc ,Us Food Drug Administration ,Prnewswire Aspen Neuroscience Inc ,Trial Ready Cohort Study ,Investigational New Drug ,Drug Administration ,Aspen Neuroscience ,Nc ,